ArticleEpidemics2021
Dynamic network strategies for SARS-CoV-2 control on a cruise ship.
Article in Epidemics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Temporal Connectivity of Social Contact Networks in Urban and Rural India.Epidemiology (Cambridge, Mass.) · 2026Article
- Article
- Synchronized spread of COVID-19 in the cities of Bahia, Brazil.Epidemics · 2022Article
- Testing and Isolation Efficacy: Insights from a Simple Epidemic Model.Bulletin of mathematical biology · 2022Article
- A stochastic contact network model for assessing outbreak risk of COVID-19 in workplaces.PloS one · 2022Article
- A review of COVID-19 transmission dynamics and clinical outcomes on cruise ships worldwide, January to October 2020.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2022Review
- Social contact patterns among employees in 3 U.S. companies during early phases of the COVID-19 pandemic, April to June 2020.Epidemics · 2021Article
- Harnessing testing strategies and public health measures to avert COVID-19 outbreaks during ocean cruises.Scientific reports · 2021Article
Corrections and comments
- Update of
Authors and funding
5 authors.
Funding
Abstract
SARS-CoV-2 outbreaks have occurred on several nautical vessels, driven by the high-density contact networks on these ships. Optimal strategies for prevention and control that account for realistic contact networks are needed. We developed a network-based transmission model for SARS-CoV-2 on the Diamond Princess outbreak to characterize transmission dynamics and to estimate the epidemiological impact of outbreak control and prevention measures. This model represented the dynamic multi-layer network structure of passenger-passenger, passenger-crew, and crew-crew contacts, both before and after the large-scale network lockdown imposed on the ship in response to the disease outbreak. Model scenarios evaluated variations in the timing of the network lockdown, reduction in contact intensity within the sub-networks, and diagnosis-based case isolation on outbreak prevention. We found that only extreme restrictions in contact patterns during network lockdown and idealistic clinical response scenarios could avert a major COVID-19 outbreak. Contact network changes associated with adequate outbreak prevention were the restriction of passengers to their cabins, with limited passenger-crew contacts. Clinical response strategies required for outbreak prevention may be infeasible in many cruise settings: early mass screening with an ideal PCR test (100 % sensitivity) and immediate case isolation upon diagnosis. Personal protective equipment (e.g., facemasks) had limited impact in this environment because the majority of transmissions after the ship lockdown occurred between passengers in cabins where masks were not consistently used. Public health restrictions on optional leisure activities like these should be considered until longer-term effective solutions such as a COVID-19 vaccine become widely available.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.